Back to User profile » Dr Ying-Ming Tsai
Papers published by Dr Ying-Ming Tsai:
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Pemetrexed had significantly better clinical efficacy in patients with stage IV lung adenocarcinoma with susceptible EGFR mutations receiving platinum-based chemotherapy after developing resistance to the first-line gefitinib treatment
Yang CJ, Tsai MJ, Hung JY, Liu TC, Chou SH, Lee JY, Hsu JS, Tsai YM, Huang MS, Chong IW
OncoTargets and Therapy 2016, 9:1579-1587
Published Date: 16 March 2016
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Poorer prognosis in Taiwanese female ever smokers with stage IV lung adenocarcinoma who were readministered a tyrosine kinase inhibitor
Yang CJ, Tsai MJ, Hung JY, Tsai YM, Lee JY, Chou SH, Liu TC, Shen MC, Huang MS, Chong IW
OncoTargets and Therapy 2016, 9:1511-1518
Published Date: 15 March 2016